← Back to Search

Bisphosphonate

1 for Lower Back Pain

Phase 1
Waitlist Available
Led By Marco Pappagallo, MD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up length of study
Awards & highlights

Study Summary

The purpose of this study is to determine the test dose of pamidronate for treatment of low back pain in terms of safety, tolerability, and pain relief.

Eligible Conditions
  • Lower Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~length of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and length of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Best dose of pamidronate to be tested in a future large-scale study for treatment of low back pain. Criteria for best dose relate to safety/efficacy of the tested doses in this pilot trial

Trial Design

1Treatment groups
Active Control
Group I: 1Active Control1 Intervention

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
860 Previous Clinical Trials
524,432 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,340 Previous Clinical Trials
649,320 Total Patients Enrolled
Marco Pappagallo, MDPrincipal InvestigatorThe Mount Sinai Medical Center
7 Previous Clinical Trials
1,554 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain
2003. "A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00101790.
All > Low Back Pain > Back Pain
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top